Altria: It's Time To Return To This High Dividend Yield Opportunity (Rating Upgrade)
Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See ...
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...
Convenience Store News1d
Latest Rule to Cap Nicotine in Cigarettes Prompts Mixed Responses
Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and ...
STAT2d
FDA authorizes sale of Zyn nicotine pouches, saying public health benefits outweigh risk
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...
US regulators propose capping nicotine in cigarettes at non-addictive levels
U.S. regulators are proposing to cap the amount of nicotine in cigarettes at non-addictive levels, in a potential world-first ...
Morgan Stanley Begins Coverage on Altria Group (NYSE:MO)
Morgan Stanley began coverage on shares of Altria Group (NYSE:MO – Free Report) in a research note issued to investors on Thursday morning, Marketbeat Ratings reports. The brokerage issued an equal ...
Altria: A High-Yielding Dividend Gem To Buy Now
Discover why Altria may be a strong investment opportunity, with potential for significant total returns and a possible ...
FDA authorizes marketing of 20 Zyn nicotine pouch products
The Food and Drug Administration authorized the marketing of 20 Zyn nicotine pouch products through the premarket tobacco product application ...
Hosted on MSN3d
Altria Group Earnings Preview: What to Expect
Altria Group, Inc. (MO), headquartered in Richmond, Virginia, is a leading producer and seller of smokeable and oral tobacco ...